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Hexachlorobenzene (HCB) is a widespread,
highly lipophylic environmental pollutant
that accumulates in biologic systems.
Nowadays, the major source of HCB is
industrial emission as a by-product of the
manufacture of organochlorinated products. 
Porphyria cutanea tarda (PCT) is the
most common of human porphyria. This
disease is caused by a partial deficiency of the
uroporphyrinogen decarboxylase (UROD)
enzyme in the liver, and it is one of the
major potential toxic manifestations of this
chemical, as several studies in experimental
animals have demonstrated (1,2). The dis-
ease is characterized biochemically by
marked increases in uroporphyrin and hep-
taporphyrin in urine (3).
Although the existence of a link between
HCB and porphyria has been known for a
long time, the porphyrinogenic effect of this
chemical on humans has not been widely
studied. The first cases of PCT induced by
HCB in humans were reported in southeast-
ern Turkey in the late 1950s (4). The out-
break was related to the inadvertent
ingestion of seed wheat contaminated with
the fungicide HCB. It was estimated that
5,000 subjects developed acquired PCT. The
syndrome commonly consisted of weight
loss, weakness, thyromegaly, hepatomegaly,
gross porphyrinuria, hypertricosis, and pho-
tosensitive dermopathy (4). Children were
affected disproportionately more than adults;
it was estimated that over 3,000 children
under age 16 who had ingested contaminated
bread developed the disease. However, the
group most severely affected by this chemical
were breast-fed babies. Over 1,000 babies
born to mothers with clinical symptoms of
PCT or who had ingested contaminated
bread during gestation or lactation or both
died before the age of 12 months with weak-
ness, convulsions, and toxic erithema known
as “pembe yara.” Pembe yara was caused by
HCB intake both transplacentally and via
mother’s milk (5). This was the first evidence
that HCB is toxic to young children.
Unfortunately, no dose–response data were
recorded for the Turkish outbreak (6).
HCB and other organochlorine com-
pounds are not readily metabolized or
excreted. In pregnant mothers they persist in
placenta tissue and are consequently
transferred transplacentally from mother to
fetus (7–9). However, little information is
available about the relation between prenatal
exposure to HCB and porphyrin metabolism
in human populations. Several studies have
reported the effects of other organochlori-
nated compounds such as polychlorinated
biphenyls, dichlorodiphenyldichloroethylene,
dichlorodiphenyltrichloroethane, and 2,3,7,8-
tetrachlorodibenzo-p-dioxin (10–13) on uri-
nary porphyrin excretion in children and
neonates, but the impact of HCB on these
populations has not been analyzed to date.
Previous studies made by our group, in
adults of the same population, showed high
atmospheric levels of HCB (mean 35 µg/m3)
in Flix (Tarragona, Catalonia, Spain), a rural
village of 5,000 inhabitants located near a
chlorinated solvent factory (14). We per-
formed a cross-sectional epidemiologic study
of the health effects of HCB on the popula-
tion older than 14 years. We found high
serum levels of HCB (mean 36.7 ng/mL),
the highest ever recorded (15,16). The eval-
uation of the urinary pophyrin excretion
showed one case of subclinical PCT and 5
subjects with coproporphyrinuria. No associ-
ation between HCB serum concentrations
and total urinary porphyrin excretion was
found. The porphyrin profile of the highly
exposed subjects was normal (17). Analysis
of HCB metabolism and excretion in urine
and feces revealed a strong correlation
between HCB serum concentrations and
pentachlorobenzenetiol (PCBT) in urine
(18) and unmetabolized HCB (19).
Although PCT has been associated most
frequently with excessive alcohol consump-
tion in middle-aged men, it has also been
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The existence of a link between hexachlorobenzene (HCB) and porphyria cutanea tarda has been
known for a long time. However, the epidemiologic data on effects on health caused by prenatal
exposure have not provided convincing evidence that HCB alters porphyrin metabolism. Our
objectives were to analyze urinary porphyrin excretion and HCB in maternal serum and fetal cord
blood in neonates born in a village (Flix) near a chlorinated solvent factory, to detect possible
adverse effects in urinary porphyrin excretion caused by prenatal exposure, and to assess their
relationship with HCB blood levels. We conducted a cross-sectional study in the Porphyria Unit
at a tertiary care facility in Barcelona, Spain, and the Pediatric Unit of the Móra d’Ebre Hospital,
the reference hospital of the study area. We included in the study all neonates (n = 68) born in
Móra d’Ebre Hospital 1997–1999 and their mothers. We obtained 68 urine specimens of single-
ton neonates on the third day after birth to test for urinary porphyrin excretion. We obtained 52
fetal cord blood and 56 maternal serum samples for HCB analysis. Total urinary porphyrins were
quantified using spectrofluorometry. Porphyrin profile was determined by HPLC. Serum HCB
was analyzed by gas chromatography coupled with electron capture detection. In total population,
median HCB levels were 1.08 ng/mL in cord blood and 3.31 ng/mL in maternal serum. Total
urinary porphyrin concentration was 37.87 µmol/mol creatinine. Coproporphyrin I and copro-
porphyrin III were the major porphyrins excreted. We found no positive relationship between
urinary porphyrin excretion and HCB levels. However, we observed an association between
maternal smoking and coproporphyrin excretion. Although high environmental levels of HCB are
reported in the town of Flix, we found no alteration in urinary porphyrin excretion. Key words:
coproporphyrin I, coproporphyrin III, hexachlorobenzene, neonates, porphyria, uroporphyrin.
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reported in children (20). The availability of
a population with high exposure to HCB
over the last four decades prompted us to
investigate the possible existence of subclini-
cal changes in urinary porphyrin excretion in
neonates exposed transplacentally to this
chemical, so as to broaden our understand-
ing of its toxic effects. 
Materials and Methods
Study population. We performed a cross-sec-
tional study of all 68 full-term singleton
neonates born in the Department of
Obstetrics at the Móra d’Ebre Hospital
between 1997 and 1999. Thirty-eight were
from the exposed population (Flix); the
other 30 were from neighboring villages and
were selected as a nonexposed group. 
Information on maternal history, sex,
and fetal exposure to alcohol and tobacco
consumption was obtained through a ques-
tionnaire prepared ad hoc for this study. 
Using urine collection bags, we collected
fresh urine samples on the third day after
birth from 68 full-term neonates. Specimens
were immediately frozen and stored at
–20°C until assayed. We obtained 52 fetal
cord blood (23 from exposed vs. 29 nonex-
posed) and 56 maternal serum (24 exposed
vs. 32 nonexposed) samples for HCB analy-
sis. Informed consent was obtained from
parents before collection. 
Urinary porphyrin measurements. All
urine specimens were analyzed without previ-
ous knowledge of HCB levels in fetal cord
blood and maternal serum. We determined
total urinary porphyrin concentrations by
spectrofluorometry (model F-2000; Hitachi
Ltd., Tokyo, Japan) (21). We analyzed uri-
nary porphyrin excretion patterns by HPLC.
Briefly, 1 mL of urine sample was acidified
with 50 µL of concentrated HCl, and 200 µL
of this solution was injected. For HPLC
determination, we used Waters equipment
(Waters Corp., Milford, MA, USA): two
pumps (model 515), an autosampler injector
(model 717 plus), and Millennium32 soft-
ware. The porphyrins were detected using a
fluorescence detector (model 474), under the
following conditions: excitation 405 nm and
emission 618 nm, both with bandwidths of
18 nm. Porphyrin separation was achieved
with an analytic column BDS-Hypersil (250
× 4.6 mm, 5 µm particle size; Shandon
HPLC, Cheshire, UK) and a gradient from
100% of solvent A (10:90 acetonitrile/ammo-
nium acetate 1M pH 5.16) to 95% of solvent
B (10:90 acetonitrile/methanol) in 25 min.
The flow rate was 1.2 mL/min (22).
Urinary creatinine determinations. We
measured urinary creatinine concentration
(mmol/L) using the Jaffe method (23) on a
Cobas Miras (Roche Diagnostics, F.
Hoffmann-La Roche Ltd., Basel, Switzerland).
Creatinine was analyzed in the department
of biochemistry at the Hospital Clínic,
Barcelona. 
Analysis of organochlorine compounds.
All HCB sera samples were extracted with n-
hexane and the extracts blindly assayed with
gas chromatography coupled to electron cap-
ture detection (GC-ECD) in the department
of environmental chemistry at the Consejo
Superior de Investigacion Cientifica in
Barcelona.
Statistical analysis. Because the data dis-
tribution on porphyrins was skewed, we per-
formed a logarithmic transformation. The
variable HCB was treated as a trichotomous
variable with values HCB < 2.43, 2.43 <
HCB < 4.07, and HCB > 4.07 ng/mL
because the relationship between HCB and
uroporphyrin isomer I (UPI), copropor-
phyrin isomer I (CPI), and coproporphyrin
isomer III (CPIII) was not linear.
The concentration of porphyrins below
the quantification limit was set at half the
limit of detection. To evaluate the relation-
ship among porphyrins (total porphyrin,
UPI, CPI, CPIII) and possible confounding
variables (sex, gestational age, maternal age,
birth weight, alcohol, and tobacco) we used
linear regression models. 
We performed multiple linear regression
analysis to examine the relationship between
porphyrins (UP, CPI, CPIII) and HCB lev-
els (fetal cord serum and maternal serum)
adjusting for potential confounding variables
such as sex, tobacco, alcohol, and maternal
age. Statistical significance was defined as p <
0.05. All statistical analyses were performed
using Stata (StataCorp., College Station,
TX, USA). 
Results 
The anthropometric variables, gestational
age, maternal age, and alcohol and tobacco
habits in mothers of the population under
study are shown in Table 1. Exposed and
nonexposed neonates differed in terms of
maternal alcohol consumption and smoking
during pregnancy. The number of males
born in the exposed group was higher than
in the nonexposed group.
We found detectable levels of HCB
(nanograms per milliliter) in all samples of
fetal cord blood and maternal serum. The
medians and interquartile ranges are shown
in Table 2. In fetal cord blood 59% of cases
showed HCB concentrations over 1 ng/mL,
a figure that rose to 91% in maternal blood.
HCB levels in both sets of samples were
slightly higher in the exposed group than in
the nonexposed group; the difference was
statistically significant (p < 0.05).
We analyzed total porphyrin concentra-
tions and individual porphyrins (HPLC) in
all 68 urine specimens. The median and
interquartile ranges for total porphyrin and
the main individual porphyrins excreted are
summarized in Table 2. CPI, CPIII, and
UPI were the major porphyrins excreted in
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Table 1. Characteristics of the study groups.
Total population (n = 68) Exposed (n = 38) Nonexposed (n = 30)
Variable Mean (SD) Mean (SD) Mean (SD)
Weight (g) 3,281 (457) 3,244 (503) 3,328 (396)
Height (cm) 49.5 (2.0) 49.4 (2.1) 49.6 (1.8)
Gestational age (weeks) 39.6 (1.5) 39.7 (1.5) 39.5 (1.5)
Maternal age (years) 30.8 (4.5) 30.3 (4.3) 31.5 (4.7)
Sex M/F 37/31 27/11 10/20
Maternal smoking during pregnancy (%)a 27.9 39.5 13.3
Maternal drinking during pregnancy (%)b 20.6 26.3 13.3
Abbreviations: F, females; M, males. 
aAt least a cigarette a day during gestation. bModerate/high alcohol intake (as at least once a week) during gestation.
Table 2. Median (interquartile range) of HCB levels in fetal cord serum and maternal serum, and urinary
prophyrin excretion in the study groups
Total population Exposed Nonexposed
Variable Median (IQR) Median (IQR) Median (IQR)
ng/mL
HCB cord blood (n = 52) 1.08 (0.73–1.67) 1.41 (0.86–2.05) 0.92 (0.53–1.21)*
HCB maternal serum (n = 56) 3.35 (2.11–5.47) 3.83 (2.92–5.71) 2.44 (1.52–3.77)*
µmol/mol creatinine (n = 68)
Total porphyrin 37.3 (27.9–50.5) 39.2 (27.4–56.6) 36.2 (27.9–48.3)
UPI 5.0 (1.9–6.6) 5.0 (2.2–6.7) 5.1 (1.6–6.8)
UPIII 0.05 (0.05–0.5) 0.05 (0.05–0.7) 0.05 (0.05–0.05)
UPI + UPIII 5.6 (1.9–7.3) 5.6 (2.2–7.5) 5.5 (1.6–6.8)
CPI 13.7 (6.3–18.7) 15.1 (6.7–21.5) 9.8 (5.3–17.1)
CPIII 10.2 (5.2–20.5) 11.6 (5.8–22.7) 7.4 (4.7–12.7)*
CPI + CPIII 23.0 (12.6–38.7) 27.8 (14.0–42.9) 19.2 (12.5–30.5)
IQR, interqualtile range (25th–75th percentile). 
*p < 0.05 compared with exposed population using Kruskal-Wallis nonparametric test for equality of populations.
both groups. Neonates from the exposed
group had higher levels of CPIII (p < 0.05)
than did those of the nonexposed group.
The uroporphyrin fraction was the third
most excreted porphyrin; more UPI was
excreted than UPIII (Figure 1).
We detected the heptacarboxylporphyrin
isomer I (hepta I) only in four cases in the
exposed group (10.26%), at very low con-
centrations (median 0.21). We detected the
heptaporphyrin isomer III (hepta III) in 14
cases (35.9%) in the exposed group and
three cases (9.4%) of the nonexposed group
(p < 0.012). All values were within the nor-
mal range (median 0.94). We found no dif-
ference in HCB concentrations between the
subjects with and without hepta III. The
hexa and pentacarboxylporphyrin fractions
were not detected in any group.
Table 3 shows the relationship among
total porphyrin, UPI, CPI, and CPIII con-
centrations, HCB levels, and other charac-
teristics of the cohort studied. We observed a
decrease of urinary porphyrin excretion with
HCB levels. Moreover, the neonates in the
highest tertile of HCB had lower levels of
CPI and CPIII (p < 0.05).
In neonates born to cigarette-smoking
mothers, the excretion of total porphyrin
and CPIII fraction were higher than in non-
smokers (p < 0.05). 
The association between CPIII and the
exposed group disappeared after adjusting
for smoking (Table 4), because mothers
from the exposed group smoked more dur-
ing pregnancy. However, the negative associ-
ation of CPI and CPIII with the highest
tertile of HCB did not disappear after
adjusting for smoking and alcohol, and
remain statistically significant for CPI
(p < 0.05).
Discussion
Because long-term exposure to HCB can
cause its accumulation in humans, adverse
effects on health are expected in exposed
populations. Public attention has been
drawn to HCB when high concentrations
are found in the environment, as is the case
in Flix (14,15). Detecting subtle alterations
in urinary porphyrin excretion may be one
of the most useful methods for identifying
the biologic response to environmental
chemicals. 
In the Turkish outbreak, high HCB lev-
els were found in maternal milk (6), but uri-
nary porphyrin excretion was not studied in
the breast-fed babies. Porphyria acquired
transplacentally in response to HCB expo-
sure has been demonstrated in experimental
animals (24) but little is known about the
effects in infants (25). The present study is
the first to analyze the urinary porphyrin
excretion in human neonates in relation to
HCB levels in cord blood and maternal
serum. The neonate’s HCB burden depends
on the mother’s level of contamination. In
this cohort, the mothers had been living for
a long time in a population with the highest
environmental (mean 35 ng/m3) (14) and
serum (36.7 ng/mL) levels of this chemical
ever reported (15), although in recent years
HCB levels in the area around Flix have
decreased (16) because of protective mea-
sures implemented in the factory. However,
the HCB concentrations found in cord
blood of exposed neonates and in maternal
serum were still higher than in the nonex-
posed group (Table 2). The values in both
exposed and nonexposed groups are higher
than those found in neonates born in
Germany between 1994 and 1995 (median
0.61 ng/mL), but lower than neonates born
in Germany between 1984 and 1985
(median 2.03 ng/mL) (26). These values in
Europe are much higher than those found in
Canada (median 0.04 ng/mL) (27) during
1993–1995 and the United States (median
0.03 ng/g) during 1993–1998 (28). 
The results of this study showed no alter-
ation in total urinary porphyrin excretion.
The quantitative analysis did not reveal any
differences between groups concerning total
porphyrin excretion (Table 2). The total uri-
nary porphyrin concentrations detected here
are within the ranges observed in other stud-
ies of neonates and pediatric groups
(29–32). Unfortunately, in the Turkish
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Table 3 . Median (IQR) of variables UPI, CPI, and CPIII, by birth weight, gestational age, maternal age, sex,
smoking, alcohol, HCB maternal serum, and HCB fetal cord blood. 
Variable No. Total porphyrin UPIa CPIa CPIIIa
Birth weight (g)
< 2,500 3 41 (29–57) 5.3 (0.1–10) 17 (15–22) 25 (6.4–32)
≥ 2,500 65 37 (27–50) 5.0 (2.0–6.6) 13 (6.2–18) 10 (5.0–19)
Gestational age (weeks)
< 37 2 37 (33–41) 5.1 (0.1–10) 24 (23–25) 15 (7.4–23)
≥ 37 66 37 (27–52) 5.0 (2.2–6.6) 13 (6.2–17) 10 (5.0–20)
Maternal age (years)
≤ 30 28 39 (33–57) 5.5 (2.7–7.3) 15 (7.3–23) 11 (6.8–22)
> 30 40 37 (27–49) 4.8 (1.6–6.4) 12 (5.1–17) 7.6 (3.5–21)
Sex
Male 37 38 (29–49) 5.8 (2.7–7.5) 15 (6.8–21) 11 (3.8–20)
Female 31 37 (25–57) 4.0 (0.7–6.3) 10 (5.2–17) 9.8 (5.8–21)
Smoker
No 49 35 (26–43) 4.9 (2.4–6.6) 12 (5.3–17) 7.4 (4.1–18)
Yes 19 47 (40–60)* 5.8 (0.1–6.9) 15 (9.0–22) 16 (10–23)*
Alcohol
No 54 36 (26–48) 4.8 (1.4–6.6) 14 (6–18) 10 (4.7–21)
Yes 14 42 (37–59) 6.0 (4.1–8.0) 15 (6.3–23) 10 (6.4–20)
HCB fetal cord (ng/mL)
<0.8 16 48 (28–70) 6.5 (2.6–8.7) 13 (7.3–23) 13 (5.2–23)
0.8–1.48 20 39 (35–53) 5.9 (3.8–6.6) 15 (8.6–19) 13 (7.4–23)
> 1.48 16 26 (19–39)* 3.1 (0.9–6.2) 6.2 (2.9–13)* 5.1 (2.1–11)*
HCB mother serum (ng/mL)
< 2.43 19 48 (34–68) 6.1 (3.4–8.8) 15 (9.7–23) 7.4 (5.1–21)
2.43–4.07 17 40 (30–45) 5.8 (3.3–6.7) 17 (8.3–22) 12 (7.7–22)
> 4.07 20 29 (25–38)* 4.5 (1.6–6.2) 6.8 (5.0–14)* 7.1 (2.1–18)
IQR, interquartile range. 
aµmol/mol creatinine. *p < 0.05 using Kruskal-Wallis nonparametric test for equality of populations. 















outbreak, urinary porphyrin concentrations
were not recorded. Although levels of por-
phyrins were within the normal range (even
subclinical normality), we observed a
decrease of CPI and CPIII with the highest
tertile of HCB (only statistically significant
for CPI). This negative association between
CP fractions and HCB levels does not agree
with the results on experimental porphyria
where moderate increases of CP are observed
at an early stage (2). However, the small
number of subjects and the known varia-
tions on the profile of porphyrin excretion
during the first days of life preclude a firm
conclusion.
The increase of the uroporphyrin and
heptaporphyrin fractions is a specific indica-
tor of UROD deficiency. In our cohort, no
neonates showed subclinical alterations in
the urinary porphyrin profile. CPI was the
major porphyrin excreted, in accordance
with the normal pattern observed in
neonates < 7 days of age, followed by CPIII
fraction (32). We found no difference in
CPI excretion between both groups, but
there was a statistically significant difference
in CPIII excretion between exposed and
nonexposed groups (Table 2). However, the
increase in CPIII excretion cannot be
explained by higher HCB concentrations in
blood because no positive association was
found between the two variables. The UP
fraction, the third most excreted porphyrin,
was also within normal ranges (30,31).
Although the heptaporphyrin fraction is
present most frequently in exposed popula-
tions, we found no evidence of a relation-
ship between the presence of this porphyrin
and HCB concentrations in blood. This
lack of association between urinary por-
phyrin excretion and HCB levels has been
observed previously in adults of the same
population (17). 
The information obtained through the
questionnaire reflected differences in
response between populations studied
regarding tobacco and alcohol habits. In the
exposed group the proportion of mothers
who smoked and consumed alcohol was
higher than in the nonexposed (Table 1),
and a relationship between CP excretion and
tobacco smoking was found (Table 3).
Therefore, the greater CPIII excretion
detected in the exposed population may be
explained by the deleterious effect of tobacco
smoking. Because some cytochrome P450
isoenzymes, such as P4501A2, are involved
in disturbances of porphyrin metabolism a
possible indirect effect of smoke through a
P450 induction cannot be ruled out (33). 
We conclude that although high environ-
mental levels of HCB have been reported in
Flix, no major alteration in urinary por-
phyrin excretion is present in neonates. The
placental transfer of HCB to the fetus may
not reach the threshold for subclinical alter-
ation in porphyrin excretion pattern, consid-
ering that HCB levels in mothers are not
high at the time of the study. Our findings
show only a greater urinary CPIII excretion
in the exposed population. However, we
found no evidence for an association between
HCB levels and the amount of CP. Probably,
this increases of CP III is caused by a higher
tobacco consumption by the mothers in this
group, but further research must be done to
elucidate the tobacco effect on porphyrin
metabolism. The HCB levels described here
could be considered a guideline for evaluat-
ing further research in other populations.
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